Canadian Spondylitis Association

Tag: awareness

  • RINVOQ Survey

    The Common Drug Review (CDR) and Institut national d’excellence en santé et en services sociaux (INESSS) are currently welcoming patients to provide input to patient organizations on the manufacturer’s submission for upadacitinib (Rinvoq) for the treatment of ankylosing spondylitis (AS).Organizations supporting patients living with ankylosing spondylitis (AS) develop these patient input submissions whenever a drug…

  • Michael’s Story

    It has been 30 years since I was diagnosed with ankylosing spondylitis in 1991. Prior to diagnosis I went through ten awful years that those living with axial spondyloarthritis will be familiar with: painful days and more painful, sleepless nights; a search for answers (pre-Internet) while being bounced around between doctors, chiropractors and physiotherapists; an…

  • PsA Roundtable

    Do you live with Psoriatic Arthritis (PsA)? A leading pharmaceutical company is holding a patient advisory board to learn more about PsA